This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Precision medicine sparks Alzheimer's hope with targeted trials
At the Alzheimer's Association conference in Chicago researchers see potential in precision medicine and adaptive trial designs to treat Alzheimer's. BAN2401 shows amyloid reduction and slower decline in high doses, while Anavex 2-73 links genetic variants to meaningful cognitive gains in a small 32 patient study. A larger trial in Australia and North America is planned.
MENTIONED IN THIS ARTICLE
Alzheimer’s Association
Chicago
U.S
Food and Drug Administration
Scott Gottlieb
James Hendrix
The
Hendrix
Anavex
Australia
North America
Christopher Missling
Anavex Life Sciences Corp
Deepak Bhatt
Bhatt
Brigham and Women’s Hospital
Boston
Os Angeles Times